Using the Cell-based ELISA Patient and healthy volunteer antibody responses were assessed using the cell-based ELISA. We evaluated the reactivity of the supernatant from each B cell culture to tumor cells relative to negative and positive control antibodies. In order to compare antitumor antibody responses to metastatic and primary melanoma cells between patients and healthy volunteers, and among patient groups, optical densities (OD) were normalized using the following formula: